New hope for tough cancers: first patients test experimental drug
Disease control
Recruiting now
This is the first time a new drug called AT03-65 is being tested in people. The main goal is to find a safe dose for adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will give the drug by IV and carefully monitor patients for side…
Phase: PHASE1 • Sponsor: Axcynsis Therapeutics Pte Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC